Better Therapeutics (BTTX) executive Karbe bought 50,000 shares for $105K at $2.09
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Frank Karbe (executive at Better Therapeutics Inc., BTTX) reported that they bought 50,000 shares for $105K at $2.09 on Sep 15, 2022. After these transactions the filing shows 50,000 shares held directly.
- Reporting person
- Karbe Frank
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Sep 15, 2022 | Open-market purchase (P) | Common Stock1 | +50,000 | $2.09 | $105K | 50,000 direct |
Holdings before and after
- Common Stock: 0 to 50,000 direct
Footnotes from the filing
- 1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.06 to $2.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Transaction codes in this filing
- Open-market purchase:
- Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
FAQ
What did Karbe report in this BTTX Form 4?
Frank Karbe (executive at Better Therapeutics Inc., BTTX) reported that they bought 50,000 shares for $105K at $2.09 on Sep 15, 2022. After these transactions the filing shows 50,000 shares held directly.
How many BTTX shares does Karbe hold after this filing?
The filing shows 50,000 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code P mean on an SEC Form 4?
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Historical context for BTTX
Earlier insider filings at BTTX
- Sep 14, 2022SEC Form 4: Heinen Mark bought $97,000 worth of shares (50,000 units at $1.94), increasing direct ownership by 250% to 70,000 units
- Jul 7, 2022SEC Form 4 filed by Karbe Frank
- Jun 28, 2022SEC Form 4: Heinen Mark bought $4,000 worth of shares (2,281 units at $1.75)
- Jun 16, 2022SEC Form 4: Armanino Andrew J. bought $20,846 worth of shares (15,000 units at $1.39)
- Jun 14, 2022SEC Form 4: Parker Geoffrey M. bought $36,182 worth of shares (25,000 units at $1.45), increasing direct ownership by 167% to 40,000 units
Quantisnow market dataNASDAQ
BTTX
Better Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Get push alerts for BTTX
Full BTTX profile on Quantisnow Follow BTTX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time